Klingenstein Fields & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $268K | Hold |
9,547
| – | – | 0.01% | 160 |
|
|
2025
Q4 | $238K | Buy |
9,547
+200
| +2% | +$5.04K | 0.01% | 173 |
|
|
2025
Q3 | $238K | Hold |
9,347
| – | – | 0.01% | 181 |
|
|
2025
Q2 | $227K | Sell |
9,347
-4,162
| -31% | -$97.1K | 0.01% | 175 |
|
|
2025
Q1 | $342K | Hold |
13,509
| – | – | 0.01% | 135 |
|
|
2024
Q4 | $358K | Sell |
13,509
-3,753
| -22% | -$102K | 0.01% | 133 |
|
|
2024
Q3 | $500K | Sell |
17,262
-330,925
| -95% | -$9.65M | 0.02% | 120 |
|
|
2024
Q2 | $9.74M | Sell |
348,187
-6,531
| -2% | -$180K | 0.4% | 67 |
|
|
2024
Q1 | $9.84M | Buy |
354,718
+32,578
| +10% | +$904K | 0.41% | 69 |
|
|
2023
Q4 | $9.27M | Sell |
322,140
-9,340
| -3% | -$282K | 0.41% | 67 |
|
|
2023
Q3 | $11M | Buy |
331,480
+8,427
| +3% | +$298K | 0.54% | 64 |
|
|
2023
Q2 | $11.8M | Sell |
323,053
-5,095
| -2% | -$198K | 0.55% | 64 |
|
|
2023
Q1 | $13.4M | Buy |
328,148
+794
| +0.2% | +$34.3K | 0.67% | 58 |
|
|
2022
Q4 | $16.8M | Sell |
327,354
-7,487
| -2% | -$359K | 0.87% | 48 |
|
|
2022
Q3 | $14.7M | Buy |
334,841
+21,446
| +7% | +$1.04M | 0.81% | 50 |
|
|
2022
Q2 | $16.4M | Buy |
313,395
+1,905
| +0.6% | +$97.1K | 0.85% | 48 |
|
|
2022
Q1 | $16.1M | Sell |
311,490
-3,926
| -1% | -$204K | 0.69% | 56 |
|
|
2021
Q4 | $18.6M | Sell |
315,416
-728
| -0.2% | -$36.1K | 0.75% | 54 |
|
|
2021
Q3 | $13.6M | Sell |
316,144
-111,400
| -26% | -$4.94M | 0.58% | 61 |
|
|
2021
Q2 | $16.7M | Buy |
427,544
+13,984
| +3% | +$544K | 0.69% | 58 |
|
|
2021
Q1 | $15M | Buy |
413,560
+12,865
| +3% | +$457K | 0.68% | 58 |
|
|
2020
Q4 | $14.7M | Sell |
400,695
-11,212
| -3% | -$411K | 0.67% | 59 |
|
|
2020
Q3 | $14.3M | Buy |
411,907
+7,924
| +2% | +$278K | 0.72% | 57 |
|
|
2020
Q2 | $12.5M | Buy |
403,983
+12,179
| +3% | +$414K | 0.68% | 58 |
|
|
2020
Q1 | $12.1M | Buy |
391,804
+30,284
| +8% | +$1.03M | 0.79% | 53 |
|
|
2019
Q4 | $13.4M | Sell |
361,520
-11,936
| -3% | -$425K | 0.68% | 58 |
|
|
2019
Q3 | $12.7M | Buy |
373,456
+2,959
| +0.8% | +$108K | 0.67% | 59 |
|
|
2019
Q2 | $15.2M | Buy |
370,497
+12,661
| +4% | +$503K | 0.79% | 50 |
|
|
2019
Q1 | $14.4M | Buy |
357,836
+13,445
| +4% | +$538K | 0.77% | 50 |
|
|
2018
Q4 | $14.3M | Buy |
344,391
+5,838
| +2% | +$242K | 0.61% | 51 |
|
|
2018
Q3 | $14.2M | Sell |
338,553
-9,778
| -3% | -$376K | 0.51% | 57 |
|
|
2018
Q2 | $12M | Buy |
348,331
+5,241
| +2% | +$179K | 0.46% | 59 |
|
|
2018
Q1 | $11.6M | Buy |
343,090
+13,760
| +4% | +$473K | 0.44% | 58 |
|
|
2017
Q4 | $11.3M | Buy |
329,330
+2,329
| +0.7% | +$79.4K | 0.42% | 63 |
|
|
2017
Q3 | $11.1M | Sell |
327,001
-4,821
| -1% | -$155K | 0.43% | 61 |
|
|
2017
Q2 | $10.6M | Buy |
331,822
+13,248
| +4% | +$418K | 0.41% | 59 |
|
|
2017
Q1 | $10.3M | Sell |
318,574
-1,535
| -0.5% | -$48.4K | 0.42% | 56 |
|
|
2016
Q4 | $9.86M | Buy |
320,109
+13,297
| +4% | +$406K | 0.43% | 57 |
|
|
2016
Q3 | $9.86M | Sell |
306,812
-59,961
| -16% | -$2M | 0.45% | 52 |
|
|
2016
Q2 | $12.3M | Buy |
366,773
+6,470
| +2% | +$206K | 0.57% | 53 |
|
|
2016
Q1 | $10.1M | Buy |
360,303
+43,551
| +14% | +$1.24M | 0.51% | 52 |
|
|
2015
Q4 | $9.7M | Buy |
316,752
+57,788
| +22% | +$1.82M | 0.48% | 55 |
|
|
2015
Q3 | $7.72M | Sell |
258,964
-6,139
| -2% | -$197K | 0.38% | 59 |
|
|
2015
Q2 | $8.43M | Sell |
265,103
-10,382
| -4% | -$338K | 0.38% | 55 |
|
|
2015
Q1 | $9.09M | Buy |
275,485
+6,074
| +2% | +$193K | 0.4% | 56 |
|
|
2014
Q4 | $7.96M | Buy |
269,411
+24,222
| +10% | +$695K | 0.35% | 58 |
|
|
2014
Q3 | $6.88M | Sell |
245,189
-6,561
| -3% | -$184K | 0.3% | 65 |
|
|
2014
Q2 | $7.09M | Sell |
251,750
-4,899
| -2% | -$140K | 0.3% | 61 |
|
|
2014
Q1 | $7.82M | Sell |
256,649
-152,739
| -37% | -$4.55M | 0.35% | 53 |
|
|
2013
Q4 | $11.9M | Sell |
409,388
-4,913
| -1% | -$143K | 0.43% | 61 |
|
|
2013
Q3 | $11.3M | Sell |
414,301
-188,034
| -31% | -$5.12M | 0.44% | 62 |
|
|
2013
Q2 | $16M | Buy |
+602,335
| New | +$16.6M | 0.57% | 54 |
|
Other funds holding PFE
VCM
VPM
Klingenstein Fields & Co's PFE Position: Q1 2026 in Review
Klingenstein Fields & Co held its Pfizer (PFE) position steady in Q1 2026 at 9,547 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #160.
Klingenstein Fields & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.6M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Klingenstein Fields & Co held 9,547 shares of Pfizer worth $268K as of Q1 2026.
- Klingenstein Fields & Co left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.01% of Klingenstein Fields & Co's portfolio in Q1 2026, its #160 holding.
- Klingenstein Fields & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Klingenstein Fields & Co's Pfizer position peaked at $18.6M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.